Table of Content

1 INTRODUCTION (Page No. - 27)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 CARDIAC SAFETY SERVICES MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
           1.6.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 3 CARDIAC SAFETY SERVICES MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
          FIGURE 5 MARKET SIZE ESTIMATION FOR CARDIAC SAFETY SERVICES: REVENUE SHARE ANALYSIS
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
           2.2.2 SEGMENTATION ASSESSMENT (BY TYPE, SERVICE TYPE, AND END USER)
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH FORECAST 
          FIGURE 8 CARDIAC SAFETY SERVICES INDUSTRY: CAGR PROJECTIONS
          FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ANALYSIS 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 11 CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 CARDIAC SAFETY SERVICES INDUSTRY, BY SERVICE TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 CARDIAC SAFETY SERVICES MARKET OVERVIEW 
          FIGURE 15 RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
    4.2 NORTH AMERICA: CARDIAC SAFETY SERVICES INDUSTRY, BY TYPE AND COUNTRY (2022) 
          FIGURE 16 INTEGRATED SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 MARKET, BY SERVICE TYPE, 2023 VS. 2028 
          FIGURE 17 ECG/HOLTER MEASUREMENT SERVICES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 EUROPEAN COUNTRIES TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 CARDIAC SAFETY SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
          TABLE 2 CARDIAC SAFETY SERVICES INDUSTRY: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Rising incidence of cardiovascular diseases
                    5.2.1.2 Increasing outsourcing of services to CROs
                    5.2.1.3 High number of clinical trials for cardiac treatments
                                FIGURE 20 TOTAL CLINICAL TRIAL REGISTRATIONS WORLDWIDE (2000−2022)
           5.2.2 RESTRAINTS
                    5.2.2.1 Stringent regulations and compliance guidelines
                    5.2.2.2 Inadequacy of cardiotoxicity testing
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emergence of innovative testing methods
                    5.2.3.2 Growth in biosimilars and biologics development
           5.2.4 CHALLENGES
                    5.2.4.1 High cost of cardiac safety evaluation services
           5.2.5 TRENDS
                    5.2.5.1 Rising technological advancements
                    5.2.5.2 Transition to patient-centric approach
    5.3 TECHNOLOGY ANALYSIS 
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 21 MARKET: VALUE CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 22 MARKET: ECOSYSTEM ANALYSIS
    5.6 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 3 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.6.1 INTENSITY OF COMPETITIVE RIVALRY
           5.6.2 BARGAINING POWER OF SUPPLIERS
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 THREAT OF SUBSTITUTES
           5.6.5 THREAT OF NEW ENTRANTS
    5.7 REGULATORY ANALYSIS 
           5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.8 PRICING ANALYSIS 
    5.9 KEY CONFERENCES AND EVENTS 
          TABLE 9 MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2024)
    5.1 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 23 MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
           5.10.2 BUYING CRITERIA
                     FIGURE 24 KEY BUYING CRITERIA FOR END USERS
6 CARDIAC SAFETY SERVICES MARKET, BY TYPE (Page No. - 68)
    6.1 INTRODUCTION 
          TABLE 10 CARDIAC SAFETY SERVICES INDUSTRY, BY TYPE, 2021–2028 (USD MILLION)
    6.2 INTEGRATED SERVICES 
           6.2.1 COMPREHENSIVE DATA INTEGRATION AND IMPROVED QUALITY TO PROPEL MARKET
                    TABLE 11 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 12 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 13 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 14 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 15 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 STANDALONE SERVICES 
           6.3.1 COST-EFFECTIVE BENEFITS TO SUPPORT MARKET GROWTH
                    TABLE 16 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 17 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 18 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 19 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 20 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE (Page No. - 76)
    7.1 INTRODUCTION 
          TABLE 21 CARDIAC SAFETY SERVICES INDUSTRY, BY SERVICE TYPE, 2021–2028 (USD MILLION)
    7.2 ECG/HOLTER MEASUREMENT SERVICES 
           7.2.1 FEATURES SUCH AS TREND ASSESSMENT AND ENHANCED QUALITY METRICS TO BOOST DEMAND
                    TABLE 22 ECG/HOLTER MEASUREMENT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 23 NORTH AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 24 EUROPE: ECG/HOLTER MEASUREMENT SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 25 ASIA PACIFIC: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 26 LATIN AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 BLOOD PRESSURE MEASUREMENT SERVICES 
           7.3.1 GROWING IMPORTANCE IN CARDIOVASCULAR HEALTH ASSESSMENT TO SUPPORT GROWTH
                    TABLE 27 BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 28 NORTH AMERICA: BLOOD PRESSURE MANAGEMENT SERVICES MARKET BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 29 EUROPE: BLOOD PRESSURE MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 30 ASIA PACIFIC: BLOOD PRESSURE MANAGEMENT SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 31 LATIN AMERICA: BLOOD PRESSURE MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 CARDIOVASCULAR IMAGING SERVICES 
           7.4.1 NEED TO ASSESS DRUG EFFICACY AND SAFETY TO PROPEL DEMAND
                    TABLE 32 CARDIOVASCULAR IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 33 NORTH AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 34 EUROPE: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 35 ASIA PACIFIC: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 36 LATIN AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 THOROUGH QT STUDIES 
           7.5.1 NEED TO CONDUCT CLINICAL INVESTIGATIONS AND MEASURE MEDICAL INTERVENTION TO DRIVE GROWTH
                    TABLE 37 THOROUGH QT STUDIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 38 NORTH AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 39 EUROPE: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 40 ASIA PACIFIC: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 41 LATIN AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.6 OTHER CARDIAC SAFETY SERVICES 
          TABLE 42 MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 43 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 44 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 45 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 46 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 CARDIAC SAFETY SERVICES MARKET, BY END USER (Page No. - 92)
    8.1 INTRODUCTION 
          TABLE 47 CARDIAC SAFETY SERVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 
           8.2.1 GROWING COLLABORATIONS FOR CLINICAL TRIALS TO PROPEL MARKET
                    TABLE 48 MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 49 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 50 EUROPE: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 51 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 52 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 
           8.3.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE MARKET
                    TABLE 53 MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2021–2028 (USD MILLION)
                    TABLE 54 NORTH AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 55 EUROPE: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 56 ASIA PACIFIC: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 57 LATIN AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION)
9 CARDIAC SAFETY SERVICES MARKET, BY REGION (Page No. - 99)
    9.1 INTRODUCTION 
          TABLE 58 CARDIAC SAFETY SERVICES INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 25 NORTH AMERICA: MARKET SNAPSHOT
          TABLE 59 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 60 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 61 NORTH AMERICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
          TABLE 62 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Increasing clinical trials for drug discovery & development to drive market
                                TABLE 63 TOTAL NUMBER OF CLINICAL TRIALS REGISTERED
                                TABLE 64 US: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 65 US: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 66 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Availability of high-end facilities for drug discovery to propel market
                                TABLE 67 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 68 CANADA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 69 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.3 NORTH AMERICA: RECESSION IMPACT
    9.3 EUROPE 
          FIGURE 26 EUROPE: CARDIAC SAFETY SERVICES MARKET SNAPSHOT
          TABLE 70 EUROPE: SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 71 EUROPE: SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 72 EUROPE: SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
          TABLE 73 EUROPE: SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 High pharmaceutical production to propel market
                                TABLE 74 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 75 GERMANY: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 76 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Growth in life science research to drive market
                                TABLE 77 UK: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 78 UK: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 79 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Growing focus on biosimilars to fuel market
                                TABLE 80 FRANCE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 81 FRANCE: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 82 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Availability of funding for novel services to support market growth
                                TABLE 83 ITALY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 84 ITALY: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 85 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Presence of multinational pharma companies to drive market
                                TABLE 86 SPAIN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 87 SPAIN: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 88 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 89 REST OF EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 90 REST OF EUROPE: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 91 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.7 EUROPE: RECESSION IMPACT
    9.4 ASIA PACIFIC 
          TABLE 92 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 93 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 94 ASIA PACIFIC: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
          TABLE 95 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China to dominate APAC market for cardiac safety services
                                TABLE 96 CHINA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 97 CHINA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 98 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Supportive regulatory policies for safety measures to drive market
                                TABLE 99 JAPAN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 100 JAPAN: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 101 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Rising growth in pharmaceutical & biotechnology industries to propel market
                                TABLE 102 INDIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 103 INDIA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 104 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Rising investments by medical device companies to support market growth
                                TABLE 105 AUSTRALIA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 106 AUSTRALIA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 107 AUSTRALIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 108 REST OF ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 109 REST OF ASIA PACIFIC: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 110 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.6 ASIA PACIFIC: RECESSION IMPACT
    9.5 LATIN AMERICA 
          TABLE 111 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 112 LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 113 LATIN AMERICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
          TABLE 114 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Low costs and presence of skilled clinical investigators to drive market
                                TABLE 115 BRAZIL: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 116 BRAZIL: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 117 BRAZIL: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.2 REST OF LATIN AMERICA
                    TABLE 118 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 119 REST OF LATIN AMERICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 120 REST OF LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.3 LATIN AMERICA: RECESSION IMPACT
    9.6 MIDDLE EAST 
           9.6.1 GROWING CRO HUB TO DRIVE MARKET
                    TABLE 121 MIDDLE EAST: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 122 MIDDLE EAST: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 123 MIDDLE EAST: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.6.2 MIDDLE EAST: RECESSION IMPACT
    9.7 AFRICA 
           9.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH
                    TABLE 124 AFRICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 125 AFRICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 126 AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.7.2 AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE (Page No. - 142)
     10.1 INTRODUCTION 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 27 CARDIAC SAFETY SERVICES MARKET: STRATEGIES ADOPTED BY KEY PLAYERS (2020−2023)
     10.3 MARKET SHARE ANALYSIS 
             FIGURE 28 CARDIAC SAFETY SERVICES INDUSTRY: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
             TABLE 127 CARDIAC SAFETY SERVICES INDUSTRY: INTENSITY OF COMPETITIVE RIVALRY
     10.4 REVENUE SHARE ANALYSIS 
             FIGURE 29 REVENUE SHARE ANALYSIS FOR KEY COMPANIES (2020−2022)
     10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 
             10.5.1 STARS
             10.5.2 PERVASIVE PLAYERS
             10.5.3 EMERGING LEADERS
             10.5.4 PARTICIPANTS
                        FIGURE 30 CARDIAC SAFETY SERVICES INDUSTRY: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
     10.6 COMPETITIVE BENCHMARKING OF LEADING 25 PLAYERS (2022) 
             10.6.1 SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 128 CARDIAC SAFETY SERVICES INDUSTRY: SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS
             10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 129 MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
     10.7 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 RESPONSIVE COMPANIES
             10.7.3 DYNAMIC COMPANIES
             10.7.4 STARTING BLOCKS
                        FIGURE 31 MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
     10.8 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS (2022) 
             TABLE 130 MARKET: DETAILED LIST OF STARTUPS/SME PLAYERS
             TABLE 131 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS
     10.9 COMPETITIVE SCENARIO AND TRENDS 
             10.9.1 SERVICE LAUNCHES
                        TABLE 132 MARKET: SERVICE LAUNCHES (JANUARY 2020−SEPTEMBER 2023)
             10.9.2 DEALS
                        TABLE 133 CARDIAC SAFETY SERVICES INDUSTRY: DEALS (JANUARY 2020−SEPTEMBER 2023)
             10.9.3 OTHER DEVELOPMENTS
                        TABLE 134 CARDIAC SAFETY SERVICES INDUSTRY: OTHER DEVELOPMENTS (JANUARY 2020−SEPTEMBER 2023)
11 COMPANY PROFILES (Page No. - 157)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.1.1 LABORATORY CORPORATION OF AMERICA HOLDINGS
                        TABLE 135 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
                        FIGURE 32 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022)
             11.1.2 MEDPACE
                        TABLE 136 MEDPACE: BUSINESS OVERVIEW
                        FIGURE 33 MEDPACE: COMPANY SNAPSHOT (2022)
             11.1.3 KONINKLIJKE PHILIPS N.V.
                        TABLE 137 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                        FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             11.1.4 CLARIO
                        TABLE 138 CLARIO: BUSINESS OVERVIEW
             11.1.5 NCARDIA
                        TABLE 139 NCARDIA: BUSINESS OVERVIEW
             11.1.6 IQVIA
                        TABLE 140 IQVIA: BUSINESS OVERVIEW
                        FIGURE 35 IQVIA: COMPANY SNAPSHOT (2022)
             11.1.7 CERTARA
                        TABLE 141 CERTARA: BUSINESS OVERVIEW
                        FIGURE 36 CERTARA: COMPANY SNAPSHOT (2022)
             11.1.8 PPD, INC. (PART OF THERMO FISHER SCIENTIFIC, INC.)
                        TABLE 142 PPD, INC.: BUSINESS OVERVIEW
                        FIGURE 37 PPD, INC.: COMPANY SNAPSHOT (2022)
             11.1.9 SGS S.A.
                        TABLE 143 SGS S.A.: BUSINESS OVERVIEW
                        FIGURE 38 SGS S.A.: COMPANY SNAPSHOT (2022)
             11.1.10 ICON PLC
                        TABLE 144 ICON PLC: BUSINESS OVERVIEW
                        FIGURE 39 ICON PLC: COMPANY SNAPSHOT (2022)
             11.1.11 WUXI APPTEC
                        TABLE 145 WUXI APPTEC: BUSINESS OVERVIEW
                        FIGURE 40 WUXI APPTEC: COMPANY SNAPSHOT (2022)
             11.1.12 CHARLES RIVER LABORATORIES
                        TABLE 146 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 41 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
             11.1.13 EUROFINS SCIENTIFIC
                        TABLE 147 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 42 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
             11.1.14 FRONTAGE LABS
                        TABLE 148 FRONTAGE LABS: BUSINESS OVERVIEW
                        FIGURE 43 FRONTAGE LABS: COMPANY SNAPSHOT (2022)
             11.1.15 BANOOK GROUP
                        TABLE 149 BANOOK GROUP: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS 
             11.2.1 BIOTRIAL
             11.2.2 CELERION
             11.2.3 RICHMOND PHARMACOLOGY
             11.2.4 PHYSIOSTIM
             11.2.5 SHANGHAI MEDICILON INC.
             11.2.6 ACM GLOBAL LABORATORIES
             11.2.7 WORLDWIDE CLINICAL TRIALS
             11.2.8 NOVA RESEARCH LABORATORIES LLC
             11.2.9 BIOBEAT
             11.2.10 CRS. EXPERTS. EARLY PHASE.
12 APPENDIX (Page No. - 198)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS